Living Donor Liver Transplant: What Are the Risks?
The risk of dying as a result of a living donor liver segment removal is between 0.2-2.0%. The risk of morbidity is anywhere between 1.3% (in highly experienced centers) to 60%.
Brand Names and Generic Names of Drugs for Treatment of Living Donor Liver Transplant: What Are the Risks?
Basiliximab
Basiliximab is a monoclonal antibody, prescribed for prevention of rejection in renal transplant patients.
Ciclosporin
Ciclosporin is an immunosuppressant, prescribed for rejection of organ during transplantation.
Trade Names :
Cyclophil ME (25 mg) | Cyclophil ME (50 mg) | Cyclophil ME (100 mg) | Sandimmun Neoral 100 | Cyclomune 5% | Cyclomune 0.05% | Cyclomune 1% | Sandimmun Conc (5ml) | Sandimmun Conc | Zymmune
More ...
Lymphocyte Immune Globulin- Anti-thymocyte
Lymphocyte Immune Globulin- Anti-thymocyte is a lymphocyte-selective immunosuppressant, prescribed for prevention of organ rejection during transplantation.
Advertisement
Mycophenolate Mofetil
Mycophenolate Mofetil is an immunosuppressant, prescribed for prevention of organ rejection.
Trade Names :
Cellmune | Immutil | Mofilet | Mystead 500
More ...
Rituximab
Rituximab is a monoclol antibody, prescribed for certain types of cancer such as lymphomas, leukemia, transplant rejection and some autoimmune disorders.
Trade Names :
Reditux (100 mg) | Mabthera | Mathera (500 mg) | Reditux (500 mg)
More ...
Advertisement
